NFKBIA and neoplasm: TP suppressed RANKL-induced NF-κB activation in osteoclast precursor cells by inhibiting IκBα kinase activation, IκBα phosphorylation, and IκBα degradation effectively, and osteoclast formation induced by tumor cells was inhibited (Park, 2014).